Joined
·
7,295 Posts
This survey aims to gather data based on a diagnosis of IBS-C or Chronic Constipation; the quality of life, the treament and side effects from that treatment.In particular this is in reference to Zelnorm (tegaserod), currently indicated for IBS-constipation predominant sufferers, and going before an FDA Advisory Committee in July 2004 for its new indication of Chronic Constipation.